Table 2 Cox regression analysis to identify the association between baseline characteristics and the absence of exudative recurrence.

From: Recurrence of neovascular age-related macular degeneration after discontinuation of modified treat and extend treatment

 

OR (95%) CI

P value

Age, yrs

1.039 (0.956–1.128)

0.696

Sex, M:F

1.290 (0.360–4.625)

0.368

Rapid responder, n (%)

5.810 (1.439–23.452)

0.006*

Treatment period before cessation, mo

0.900 (0.774–1.047)

0.172

Total injection before cessation, n

1.419 (0.901–2.238)

0.131

BCVA at baseline

0.598 (0.074–4.845)

0.630

IRC at baseline, n (%)

0.815 (0.176–3.777)

0.794

  1. BCVA, best-corrected visual acuity; CI, Confidence Interval; IRC, intraretinal cyst; OR, odds ratio.
  2. *Adjustment for age, sex, diabetes duration, hypertension, and HbA1c level.
Back to article page